Seer to Report First Quarter 2023 Financial Results on May 9, 2023

Rhea-AI Summary

Seer, Inc. (Nasdaq: SEER), a life sciences company specializing in proteomics, will release its financial results for Q1 2023 after market close on May 9, 2023. A conference call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET, accessible via the Investor section of their website. Seer’s Proteograph™ Product Suite offers a breakthrough solution for unbiased proteomic analysis, streamlining laboratory workflows with engineered nanoparticles, consumables, automation, and software. Designed for research applications only, the Proteograph enables deep analysis in hours, enhancing lab efficiency.

Positive

• Scheduled webcast for Q1 2023 financial results indicates transparency to investors.
• Proteograph™ Product Suite offers innovative solution for efficient proteomic analysis.

Negative

• None.

REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarter of 2023 after market close on Tuesday, May 9, 2023. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.

About Seer
Seer™ is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph™ Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact
Carrie Mendivil
investor@seer.bio

Media Contact
Karen Possemato
pr@seer.bio

FAQ

When will Seer report its financial results for Q1 2023?

Seer will report its Q1 2023 financial results on May 9, 2023.

What time is the conference call for Seer’s Q1 2023 results?

The conference call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET.

Where can I listen to Seer’s financial results webcast?

The webcast will be available on the Investor section of Seer’s website.

What is the Proteograph Product Suite by Seer?

The Proteograph Product Suite is Seer’s platform for performing deep, unbiased proteomic analysis quickly and efficiently.